Gefitinib 250 mg Tablet – EGFR Inhibitor for Lung Cancer (NSCLC)

Gefitinib 250 mg Tablet is an oral anticancer medication used in the treatment of non-small cell lung cancer (NSCLC)with EGFR mutations. It works by inhibiting epidermal growth factor receptor (EGFR) tyrosine kinase, thereby slowing or stopping cancer cell growth.

At Medicina Overseas, we supply Gefitinib 250 mg Tablets for export, wholesale, and bulk supply, sourced from reputed Indian pharmaceutical manufacturers and compliant with international quality standards.

Available Brands (subject to availability):
Geftinat 250 mg, Gefitero 250 mg, Gefticip 250 mg, Geftistar 250 mg, Xefta 250 mg,Geffy 250 mg,Gefitrust 250 mg

We cater to hospitals, oncology clinics, pharmacies, and international distributors, offering export-ready documentation and worldwide shipping support.